Dimension scores are derived from public data and fields; weighted into the composite. Reference only.
Champel Capital is a venture capital firm based in Jerusalem, Israel, positioning itself on its website as a gateway to the “Start-up Nation.” It is not a payment gateway, acquirer, or fintech payments platform; rather, it is a capital provider focused on investing in deep-tech startups. Its investment philosophy explicitly rejects a “software-only” model and instead focuses on products and services that can change the physical world and go beyond traditional B2B SaaS.
According to the information disclosed on its website, Champel Capital covers multiple sectors, including Defense & Security, Safety, Medical devices, Insurtech, Watertech, Foodtech, Agritech, and Mobility. Its portfolio includes companies such as Lemonade, Innoviz, Vectorious, Aleph Farms, Remilk, Wi-Charge, and BodyVision, and the site also highlights selected EXIT cases. On the team side, in addition to managing partners and technical leadership, the Fund III advisory lineup is concentrated in defense, security, and strategy, including Israeli and U.S. military, policing, and urban warfare experts. Fund II advisors cover agrifood, deep medical technology, economics, and strategic communications.
From a payments/finance evaluation perspective, the official website does not disclose any information about payment methods, acquiring capabilities, wallets, clearing and settlement, cross-border payments, API integration, or merchant fees. Therefore, it should not be understood as a payment service provider. As a fund organization, the site also does not disclose management fees, carried interest, fund size, minimum subscription amount, investment stage, ticket size, or settlement/receipt timelines. Investors need to obtain further details through the Investor Portal, email, or phone.
The main website content does not specify the fund’s place of registration, regulatory licenses, manager qualifications, KYC/AML processes, or investor suitability requirements. Its “risk control” is reflected more in its investment methodology: it emphasizes founders’ vision, genuine market demand, large and growing markets, and long-term barriers to entry created by deep tech. It also states a clear preference against products that can be quickly commoditized. These are qualitative investment screening criteria, but they are not sufficient to assess the level of institutionalized risk management.
Its strengths lie in a clearly defined investment focus, notable resources in hard tech, defense and security, medical technology, and agrifood, as well as a website that presents a relatively large number of portfolio companies and exit cases. Its limitations include insufficient disclosure of fund terms, compliance information, and investor service details, making it impossible to complete thorough due diligence online. It is better suited to startups seeking Israeli deep-tech capital and industrial resources, or professional investors looking to understand Israeli hard-tech funds.
The website does not provide information on access from mainland China, RMB contributions, local payment methods, or Chinese-language services, so china_access should be considered unknown. If Chinese users are interested in Israeli or global technology investment institutions, they may also compare platforms or funds such as OurCrowd, Pitango, Viola Ventures, JVP, and aMoon. If the actual need is payment acquiring/API services, they should instead look at genuine payment service providers such as Stripe, Adyen, Checkout.com, Airwallex, and PingPong.
⚠ This review is compiled from public sources and does not constitute a purchase recommendation. Verify all facts on the vendor's official site. Verify on champelcapital.com official site.
champelcapital.com is an Israel Payments provider. TG4G tracks its product information, an overall rating of 6.0/10, and a China-accessibility score of Limited (proxy recommended). Click "Visit Official Site" to reach champelcapital.com directly.